Therefore, it can be expected that in the future activation of SIRT1 and SIRT2 or inhibition of SIRT7 by appropriate miRNA, may be a therapeutic strategy for the treatment of obesity. The gene discussed is SIRT7; the disease is obesity due to melanocortin 4 receptor deficiency.